HNSBF
Price
$3.00
Change
+$0.17 (+6.01%)
Updated
Dec 31 closing price
Capitalization
165.65M
ISCO
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Jun 5 closing price
Capitalization
1.04M
Interact to see
Advertisement

HNSBF vs ISCO

Header iconHNSBF vs ISCO Comparison
Open Charts HNSBF vs ISCOBanner chart's image
Hansa Medical AB
Price$3.00
Change+$0.17 (+6.01%)
Volume$500
Capitalization165.65M
International Stem Cell
Price$0.13
Change-$0.01 (-7.14%)
Volume$4.1K
Capitalization1.04M
HNSBF vs ISCO Comparison Chart
Loading...
View a ticker or compare two or three
VS
HNSBF vs. ISCO commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HNSBF is a Hold and ISCO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (HNSBF: $3.00 vs. ISCO: $0.13)
Brand notoriety: HNSBF and ISCO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HNSBF: 100% vs. ISCO: 88%
Market capitalization -- HNSBF: $165.65M vs. ISCO: $1.04M
HNSBF [@Biotechnology] is valued at $165.65M. ISCO’s [@Biotechnology] market capitalization is $1.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HNSBF’s FA Score shows that 0 FA rating(s) are green whileISCO’s FA Score has 1 green FA rating(s).

  • HNSBF’s FA Score: 0 green, 5 red.
  • ISCO’s FA Score: 1 green, 4 red.
According to our system of comparison, ISCO is a better buy in the long-term than HNSBF.

Price Growth

HNSBF (@Biotechnology) experienced а 0.00% price change this week, while ISCO (@Biotechnology) price change was +8.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ISCO is expected to report earnings on May 16, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
HNSBF($166M) has a higher market cap than ISCO($1.04M). ISCO YTD gains are higher at: 59.902 vs. HNSBF (0.000). ISCO has higher annual earnings (EBITDA): -338K vs. HNSBF (-523.23M). HNSBF has more cash in the bank: 250M vs. ISCO (1.31M). ISCO has less debt than HNSBF: ISCO (3.88M) vs HNSBF (1.02B). HNSBF has higher revenues than ISCO: HNSBF (182M) vs ISCO (8.53M).
HNSBFISCOHNSBF / ISCO
Capitalization166M1.04M15,946%
EBITDA-523.23M-338K154,801%
Gain YTD0.00059.902-
P/E RatioN/AN/A-
Revenue182M8.53M2,134%
Total Cash250M1.31M19,128%
Total Debt1.02B3.88M26,271%
FUNDAMENTALS RATINGS
HNSBF vs ISCO: Fundamental Ratings
HNSBF
ISCO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5440
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
6565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ISCO's Valuation (5) in the null industry is significantly better than the same rating for HNSBF (72). This means that ISCO’s stock grew significantly faster than HNSBF’s over the last 12 months.

ISCO's Profit vs Risk Rating (100) in the null industry is in the same range as HNSBF (100). This means that ISCO’s stock grew similarly to HNSBF’s over the last 12 months.

ISCO's SMR Rating (100) in the null industry is in the same range as HNSBF (100). This means that ISCO’s stock grew similarly to HNSBF’s over the last 12 months.

ISCO's Price Growth Rating (40) in the null industry is in the same range as HNSBF (54). This means that ISCO’s stock grew similarly to HNSBF’s over the last 12 months.

ISCO's P/E Growth Rating (88) in the null industry is in the same range as HNSBF (100). This means that ISCO’s stock grew similarly to HNSBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAYS4.930.22
+4.67%
Paysign
RWT5.650.07
+1.25%
Redwood Trust
YETI31.570.18
+0.57%
YETI Holdings
BLIN1.59N/A
N/A
Bridgeline Digital
CNP36.61-0.22
-0.60%
CenterPoint Energy

HNSBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HNSBF has been loosely correlated with ENSC. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if HNSBF jumps, then ENSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSBF
1D Price
Change %
HNSBF100%
N/A
ENSC - HNSBF
33%
Loosely correlated
+1.71%
CVAC - HNSBF
33%
Poorly correlated
-1.12%
MLLCF - HNSBF
27%
Poorly correlated
N/A
GNPX - HNSBF
25%
Poorly correlated
+5.43%
GRI - HNSBF
25%
Poorly correlated
-3.50%
More

ISCO and

Correlation & Price change

A.I.dvisor tells us that ISCO and HNSBF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISCO and HNSBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ISCO
1D Price
Change %
ISCO100%
N/A
HNSBF - ISCO
22%
Poorly correlated
N/A
CRDF - ISCO
20%
Poorly correlated
+7.18%
IGXT - ISCO
9%
Poorly correlated
N/A
LIXT - ISCO
7%
Poorly correlated
-3.64%
INTI - ISCO
7%
Poorly correlated
N/A
More